Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	153.3	104.14	585.58	99.96	78.23
Short-Term Investments	125.28	184.51	70.83	421.71	213.72
Cash & Cash Equivalents	278.58	288.65	656.41	521.66	291.95
Cash Growth	-3.49%	-56.03%	25.83%	78.68%	-23.86%
Receivables	105.56	98.4	96.32	53.05	47.53
Inventory	104.35	96.06	98.55	64.65	58.3
Other Current Assets	21.5	15.22	14.77	12.27	10.78
Total Current Assets	509.99	498.33	866.05	651.62	408.56
Property, Plant & Equipment	234.95	254.39	264.81	211.18	142.81
Long-Term Investments	38.46	64.38	21.99	109.48	75.77
Goodwill and Intangibles	646.5	703.79	769.14	196.07	203.93
Other Long-Term Assets	144.49	160.31	153.36	106.16	0
Total Long-Term Assets	1,064	1,183	1,209	622.89	422.51
Total Assets	1,574	1,681	2,075	1,275	831.07
Accounts Payable	15.7	15.22	10.54	10.43	12.8
Current Debt	17.44	42.77	382.59	157.07	4.94
Other Current Liabilities	64.24	89.79	127.98	85.82	89.94
Total Current Liabilities	97.38	147.77	521.12	253.33	107.67
Long-Term Debt	568.6	720.63	746.26	384.06	346.98
Other Long-Term Liabilities	38.27	37.79	77.57	17.44	21.47
Total Long-Term Liabilities	606.87	758.42	823.83	401.5	368.45
Total Liabilities	704.26	906.19	1,345	654.83	476.12
Total Debt	586.04	763.39	1,129	541.13	351.92
Debt Growth	-23.23%	-32.37%	108.61%	53.77%	20.96%
Retained Earnings	-106.8	-148.75	-211.9	-253.88	-399.4
Comprehensive Income	0.25	-0.38	0.17	0.32	0.32
Shareholders' Equity	870.13	775.01	730.41	619.69	354.94
Net Cash / Debt	-307.46	-474.74	-472.44	-19.47	-59.97
Net Cash Per Share	-5.92	-10.20	-10.35	-0.45	-1.44
Working Capital	412.61	350.56	344.93	398.3	300.88
Book Value Per Share	18.82	17.02	16.50	14.52	8.55

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).